Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Altimmune (ALT) over the last 12 years, with Q3 2025 value amounting to $700000.0.

  • Altimmune's Receivables - Other rose 13333.33% to $700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $700000.0, marking a year-over-year increase of 13333.33%. This contributed to the annual value of $400000.0 for FY2024, which is 30000.0% up from last year.
  • Per Altimmune's latest filing, its Receivables - Other stood at $700000.0 for Q3 2025, which was up 13333.33% from $400000.0 recorded in Q1 2025.
  • Over the past 5 years, Altimmune's Receivables - Other peaked at $700000.0 during Q3 2025, and registered a low of $100000.0 during Q4 2023.
  • In the last 3 years, Altimmune's Receivables - Other had a median value of $300000.0 in 2024 and averaged $342857.1.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 30000.0% in 2024, then surged by 10000.0% in 2025.
  • Over the past 3 years, Altimmune's Receivables - Other (Quarter) stood at $100000.0 in 2023, then soared by 300.0% to $400000.0 in 2024, then soared by 75.0% to $700000.0 in 2025.
  • Its Receivables - Other was $700000.0 in Q3 2025, compared to $400000.0 in Q1 2025 and $400000.0 in Q4 2024.